These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3521221)

  • 21. [Androgen insensitivity syndromes].
    Kuttenn F; Wright F; Spritzer P; Mowszowicz I; Mauvais-Jarvis P
    Ann Urol (Paris); 1987; 21(4):227-34. PubMed ID: 3314678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The frequency of androgen receptor deficiency in infertile men.
    Aiman J; Griffin JE
    J Clin Endocrinol Metab; 1982 Apr; 54(4):725-32. PubMed ID: 6801070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective androgen action at the cellular level in the androgen resistance syndromes. I. Differences between the complete and incomplete testicular feminization syndromes.
    Medina M; Chávez B; Pérez-Palacios G
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1243-6. PubMed ID: 7298803
    [No Abstract]   [Full Text] [Related]  

  • 24. Testosterone metabolism in the androgen-insensitive rat: a model for testicular feminization.
    Bardin CW; Bullock L; Blackburn WR; Sherins RJ; Vanha-Perttula T
    Birth Defects Orig Artic Ser; 1971 May; 7(6):185-92. PubMed ID: 5173750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the regulation of the concentration of androgens and androgen receptors in nuclei of prostatic cells.
    Bruchovsky N; Rennie PS; Vanson A
    Biochim Biophys Acta; 1975 Jun; 394(2):248-66. PubMed ID: 166692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced affinity of the androgen receptor for 5 alpha-dihydrotestosterone but not methyltrienolone in a form of partial androgen resistance. Studies on cultured genital skin fibroblasts.
    Pinsky L; Kaufman M; Chudley AE
    J Clin Invest; 1985 Apr; 75(4):1291-6. PubMed ID: 3872888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A physiological role for androgen actions in the absence of androgen receptor DNA binding activity.
    Pang TP; Clarke MV; Ghasem-Zadeh A; Lee NK; Davey RA; MacLean HE
    Mol Cell Endocrinol; 2012 Jan; 348(1):189-97. PubMed ID: 21872641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mutation that causes lability of the androgen receptor under conditions that normally promote transformation to the DNA-binding state.
    Kovacs WJ; Griffin JE; Weaver DD; Carlson BR; Wilson JD
    J Clin Invest; 1984 Apr; 73(4):1095-104. PubMed ID: 6323534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the pathogenesis of the incomplete forms of androgen resistance in man.
    Griffin JE; Wilson JD
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1137-43. PubMed ID: 591611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen binding in nuclear matrix of human genital skin fibroblasts from patients with androgen insensitivity syndrome.
    Brown TR; Migeon CJ
    J Clin Endocrinol Metab; 1986 Mar; 62(3):542-50. PubMed ID: 3944238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial androgen insensitivity: the Reifenstein syndrome revisited.
    Amrhein JA; Klingensmith GJ; Walsh PC; McKusick VA; Migeon CJ
    N Engl J Med; 1977 Aug; 297(7):350-6. PubMed ID: 876326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial incomplete male pseudohermaphroditism associated with impaired nuclear androgen retention. Studies in cultured skin fibroblasts.
    Eil C
    J Clin Invest; 1983 Apr; 71(4):850-8. PubMed ID: 6833492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoreactive androgen receptor expression in subjects with androgen resistance.
    Wilson CM; Griffin JE; Wilson JD; Marcelli M; Zoppi S; McPhaul MJ
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1474-8. PubMed ID: 1464650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal control of Leydig cell differentiation.
    Hardy MP; Gelber SJ; Zhou ZF; Penning TM; Ricigliano JW; Ganjam VK; Nonneman D; Ewing LL
    Ann N Y Acad Sci; 1991; 637():152-63. PubMed ID: 1785769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer.
    Lillie EO; Bernstein L; Ursin G
    Breast Cancer Res; 2003; 5(3):164-73. PubMed ID: 12793900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dihydrotestosterone binding by cultured human fibroblasts. Comparison of cells from control subjects and from patients with hereditary male pseudohermaphroditism due to androgen resistance.
    Griffin JE; Punyashthiti K; Wilson JD
    J Clin Invest; 1976 May; 57(5):1342-51. PubMed ID: 177454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the androgen receptor in male sexual differentiation.
    Batch JA; Williams DM; Davies HR; Brown BD; Evans BA; Hughes IA; Patterson MN
    Horm Res; 1992; 38(5-6):226-9. PubMed ID: 1307741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer.
    Griffiths K; Morton MS; Nicholson RI
    Eur Urol; 1997; 32 Suppl 3():24-40. PubMed ID: 9267783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen receptors in normal and abnormal male sexual differentiation.
    Brown TR; Migeon CJ
    Adv Exp Med Biol; 1986; 196():227-55. PubMed ID: 3087143
    [No Abstract]   [Full Text] [Related]  

  • 40. Androgen resistance syndromes.
    Griffin JE; Leshin M; Wilson JD
    Am J Physiol; 1982 Aug; 243(2):E81-7. PubMed ID: 7051848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.